Cargando…
Dendritic cells are defective in breast cancer patients: a potential role for polyamine in this immunodeficiency
INTRODUCTION: Dendritic cells (DCs) are antigen-presenting cells that are currently employed in cancer clinical trials. However, it is not clear whether their ability to induce tumour-specific immune responses when they are isolated from cancer patients is reduced relative to their ability in vivo....
Autores principales: | Gervais, Alban, Levêque, Jean, Bouet-Toussaint, Françoise, Burtin, Florence, Lesimple, Thierry, Sulpice, Laurent, Patard, Jean-Jacques, Genetet, Noelle, Catros-Quemener, Véronique |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1143555/ https://www.ncbi.nlm.nih.gov/pubmed/15987427 http://dx.doi.org/10.1186/bcr1001 |
Ejemplares similares
-
Polyamine deprivation prevents the development of tumour-induced immune suppression.
por: Chamaillard, L., et al.
Publicado: (1997) -
Altered dendritic cell distribution in patients with common variable immunodeficiency
por: Viallard, Jean-François, et al.
Publicado: (2005) -
Development of New Antimicrobial Oleanonic Acid Polyamine Conjugates
por: Khusnutdinova, Elmira F., et al.
Publicado: (2022) -
A Quantitative Deficiency in Peripheral Blood Vγ9Vδ2 Cells Is a Negative Prognostic Biomarker in Ovarian Cancer Patients
por: Thedrez, Aurélie, et al.
Publicado: (2013) -
Nephron Sparing Surgery for Renal Angiomyolipoma with Inferior Vena Cava Thrombus in Tuberous Sclerosis
por: Riviere, Adrien, et al.
Publicado: (2014)